Magnetic resonance metabolomics of intact tissue: A biotechnological tool in cancer diagnostics and treatment evaluation

Cancer Research

Volumn 70, Issue 17, 2010, Pages 6692-6696

  Bathen, Tone F ^a   Sitter, Beathe ^a   Sjøbakk, Torill E ^a   Tessem, May Britt ^a   Gribbestad, Ingrid S ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CITRIC ACID; DOCETAXEL; ETHANOLAMINE; FATTY ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; LACTIC ACID; LIPID; PHOSPHORYLCHOLINE; POLYAMINE; TAURINE; TUMOR MARKER;

AXILLARY LYMPH NODE; BRAIN METASTASIS; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CELL MEMBRANE; CELL METABOLISM; CELL PROLIFERATION; GLUCOSE METABOLISM; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOREGULATION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; METABOLISM; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

HUMANS; MAGNETIC RESONANCE IMAGING; METABOLOMICS; NEOPLASMS;

EID: 77956286242     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0437     Document Type: Review

References (26)

1. Sitter B, Bathen TF, Tessem M-B, Gribbestad IS. High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer. Prog Nucl Magn Reson Spectrosc 2009;54:239-54.
2. Bathen TF, Jensen LR, Sitter B, et al. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 2007;104:181-9.
3. Chan ECY, Koh PK, Mal M, et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 2009;8:352-61.
4. Cheng LL, Burns MA, Taylor JL, et al. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 2005;65:3030-4.
5. Sitter B, Bathen TF, Hagen B, Arentz C, Skjeldestad FE, Gribbestad IS. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. Magn Reson Mater Phy 2004;16:174-81. (Pubitemid 38657623)
6. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjøsne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006;19:30-40.
7. Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 2002;15:327-37.
8. 1H HR-MAS spectroscopy. Magn Reson Med 2006;55:1257-64.
9. Tzika AA, Astrakas L, Cao H, et al. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med 2007;20:199-208.
10. Cheng LL, Chang IW, Louis DN, Gonzalez RG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998;58:1825-32.
11. 1H HR-MAS total correlation spectroscopy. Magn Reson Med 2008;60:33-40.
12. De Silva SS, Payne GS, Thomas V, Carter PG, Ind TE, deSouza NM. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using magic angle spinning MRS of intact tissue. NMR Biomed 2009;22:191-8.
13. Tessem MB, Swanson M, Keshari KR, et al. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using HR-MAS spectroscopy of biopsy tissues. Magn Reson Med 2008;60:510-6.
14. Swanson MG, Vigneron DB, Tabatabai ZL, et al. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 2003;50:944-54.
15. Monleon D, Morales JM, Gonzalez-Darder J, et al. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. J Proteome Res 2008;7:2882-8.
16. Sjøbakk TE, Johansen R, Bathen TF, et al. Characterization of brain metastases using high-resolution magic angle spinning MRS. NMR Biomed 2008;21:175-85. (Pubitemid 351351010)
17. 1H NMR spectroscopy. J Proteome Res 2007;6:3944-51.
18. 1H-magnetic resonance spectroscopy of Barrett's esophageal mucosa usingmagic angle spinning techniques. Eur J Gastroenterol Hepatol 2004;16:1199-205.
19. Erb G, Elbayed K, Piotto M, et al. Toward improved grading of malignancy in oligodendrogliomas using metabolomics. Magn Reson Med 2008;59:959-65.
20. 1H NMR spectroscopy at 9.4 T. FEBS Lett 2001;494:112-6.
21. Giskeødegård GF, Grinde MT, Sitter B, et al. Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. J Proteome Res 2010;9:972-9.
22. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
23. 1H MRS. NMR Biomed 2009;23:56-65.
24. 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas. BMC Cancer 2007;7:11.
25. Opstad KS, Bell BA, Griffiths JR, Howe FA. Taurine: a potential marker of apoptosis in gliomas. Br J Cancer 2009;100:789-94.
26. Sitter B, Bathen TF, Singstad TE, et al. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 2010. Epub 2010 Jan 25.